ArticleBone marrow transplantation2023

Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Arnon Nagler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.